Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Messenger | 14 | 2024 | 1271 | 2.550 |
Why?
|
| DNA Damage | 11 | 2023 | 356 | 2.190 |
Why?
|
| Tumor Suppressor Protein p53 | 6 | 2024 | 220 | 1.960 |
Why?
|
| Polyadenylation | 7 | 2023 | 49 | 1.780 |
Why?
|
| Ubiquitin-Protein Ligases | 9 | 2018 | 91 | 1.580 |
Why?
|
| Tumor Suppressor Proteins | 9 | 2018 | 223 | 1.460 |
Why?
|
| Exoribonucleases | 6 | 2024 | 10 | 1.460 |
Why?
|
| Cleavage Stimulation Factor | 4 | 2018 | 4 | 1.250 |
Why?
|
| DNA Repair | 7 | 2018 | 198 | 1.200 |
Why?
|
| RNA-Binding Proteins | 6 | 2021 | 161 | 1.170 |
Why?
|
| RNA 3' End Processing | 3 | 2013 | 5 | 0.950 |
Why?
|
| Poly A | 3 | 2021 | 33 | 0.870 |
Why?
|
| BRCA1 Protein | 4 | 2018 | 58 | 0.870 |
Why?
|
| Estrogen Receptor alpha | 1 | 2024 | 121 | 0.820 |
Why?
|
| tau Proteins | 1 | 2023 | 186 | 0.740 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 141 | 0.720 |
Why?
|
| RNA Polymerase II | 5 | 2018 | 31 | 0.670 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2024 | 968 | 0.630 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2018 | 45 | 0.550 |
Why?
|
| Adenosine Triphosphatases | 1 | 2018 | 83 | 0.530 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 4 | 2018 | 21 | 0.530 |
Why?
|
| Cell Nucleus | 3 | 2024 | 383 | 0.500 |
Why?
|
| Carrier Proteins | 4 | 2023 | 321 | 0.490 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 333 | 0.480 |
Why?
|
| Ribonucleases | 1 | 2015 | 32 | 0.470 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 32 | 0.390 |
Why?
|
| Poly(A)-Binding Proteins | 1 | 2012 | 9 | 0.390 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 1723 | 0.390 |
Why?
|
| RNA Precursors | 2 | 2005 | 28 | 0.380 |
Why?
|
| Multigene Family | 1 | 2012 | 105 | 0.380 |
Why?
|
| Protein Binding | 5 | 2024 | 1082 | 0.370 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2011 | 31 | 0.360 |
Why?
|
| MicroRNAs | 2 | 2015 | 518 | 0.360 |
Why?
|
| Humans | 26 | 2024 | 43102 | 0.350 |
Why?
|
| 3' Untranslated Regions | 4 | 2015 | 82 | 0.320 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 2676 | 0.320 |
Why?
|
| Hela Cells | 5 | 2010 | 376 | 0.260 |
Why?
|
| Gene Expression Regulation | 5 | 2017 | 1070 | 0.250 |
Why?
|
| beta-N-Acetylhexosaminidases | 2 | 1998 | 4 | 0.250 |
Why?
|
| Ubiquitin | 3 | 2018 | 81 | 0.240 |
Why?
|
| Phosphorylation | 4 | 2023 | 986 | 0.220 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2023 | 56 | 0.200 |
Why?
|
| Protein Isoforms | 1 | 2023 | 139 | 0.200 |
Why?
|
| Research Personnel | 1 | 2024 | 206 | 0.200 |
Why?
|
| Microtubules | 1 | 2023 | 121 | 0.190 |
Why?
|
| Cell Line | 4 | 2017 | 1410 | 0.190 |
Why?
|
| Cell Cycle | 1 | 2023 | 346 | 0.180 |
Why?
|
| Ultraviolet Rays | 3 | 2017 | 118 | 0.180 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2001 | 61 | 0.170 |
Why?
|
| Sequence Deletion | 2 | 2005 | 93 | 0.150 |
Why?
|
| Casein Kinase II | 1 | 2017 | 17 | 0.140 |
Why?
|
| DNA-Binding Proteins | 2 | 2018 | 561 | 0.140 |
Why?
|
| Ubiquitination | 1 | 2018 | 62 | 0.130 |
Why?
|
| Histones | 2 | 2018 | 197 | 0.130 |
Why?
|
| Enzyme Activation | 1 | 2017 | 462 | 0.130 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 512 | 0.130 |
Why?
|
| Models, Biological | 2 | 2010 | 712 | 0.120 |
Why?
|
| Neurons | 1 | 2023 | 1263 | 0.120 |
Why?
|
| Phosphoproteins | 1 | 2017 | 206 | 0.120 |
Why?
|
| Stress, Physiological | 2 | 2017 | 172 | 0.120 |
Why?
|
| Animals | 7 | 2013 | 16992 | 0.120 |
Why?
|
| Sandhoff Disease | 1 | 1994 | 2 | 0.110 |
Why?
|
| RNA Stability | 2 | 2014 | 28 | 0.110 |
Why?
|
| DNA | 1 | 1998 | 592 | 0.110 |
Why?
|
| Eukaryotic Cells | 1 | 2014 | 35 | 0.100 |
Why?
|
| Virus Diseases | 1 | 2012 | 27 | 0.100 |
Why?
|
| Cytoplasm | 2 | 2010 | 154 | 0.090 |
Why?
|
| Models, Genetic | 1 | 2013 | 183 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 2 | 2008 | 455 | 0.090 |
Why?
|
| Glutathione Transferase | 2 | 2010 | 90 | 0.090 |
Why?
|
| RNA Splicing | 2 | 2005 | 41 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 436 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 518 | 0.080 |
Why?
|
| Argentina | 3 | 2008 | 14 | 0.080 |
Why?
|
| Mutation | 1 | 1994 | 1177 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2010 | 199 | 0.080 |
Why?
|
| Lymnaea | 1 | 2008 | 3 | 0.070 |
Why?
|
| Mice | 2 | 2013 | 6644 | 0.070 |
Why?
|
| RNA | 1 | 2010 | 266 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2008 | 296 | 0.070 |
Why?
|
| Female | 4 | 2024 | 24698 | 0.060 |
Why?
|
| Hexosaminidase B | 2 | 1998 | 3 | 0.060 |
Why?
|
| Gene Frequency | 2 | 1998 | 206 | 0.060 |
Why?
|
| 3' Flanking Region | 1 | 2005 | 3 | 0.060 |
Why?
|
| Ubiquitins | 1 | 2005 | 47 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 592 | 0.060 |
Why?
|
| Dentifrices | 1 | 1983 | 1 | 0.050 |
Why?
|
| Composite Resins | 1 | 1983 | 5 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2013 | 2157 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 228 | 0.050 |
Why?
|
| Color | 1 | 1983 | 38 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 241 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2005 | 273 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 203 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2022 | 134 | 0.040 |
Why?
|
| Insulin | 1 | 1983 | 258 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2001 | 75 | 0.040 |
Why?
|
| Rad51 Recombinase | 1 | 1999 | 7 | 0.040 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 1999 | 9 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 1999 | 28 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 291 | 0.040 |
Why?
|
| Liver | 1 | 1983 | 511 | 0.040 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1999 | 47 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2024 | 502 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2022 | 403 | 0.040 |
Why?
|
| Thymine | 1 | 1998 | 25 | 0.030 |
Why?
|
| Guanine | 1 | 1998 | 44 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 1999 | 306 | 0.030 |
Why?
|
| Mammals | 1 | 1998 | 112 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 152 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 1998 | 154 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1998 | 652 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 423 | 0.030 |
Why?
|
| Clinical Enzyme Tests | 1 | 1994 | 7 | 0.030 |
Why?
|
| Anesthesia | 3 | 1961 | 16 | 0.030 |
Why?
|
| Anesthesiology | 3 | 1961 | 7 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 1994 | 95 | 0.030 |
Why?
|
| Leukocytes | 1 | 1994 | 80 | 0.030 |
Why?
|
| United States | 1 | 2024 | 5205 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 1180 | 0.020 |
Why?
|
| Transfection | 2 | 2006 | 532 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 1542 | 0.020 |
Why?
|
| Incidence | 1 | 1994 | 1078 | 0.020 |
Why?
|
| Kinetics | 2 | 2002 | 695 | 0.020 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2008 | 10 | 0.020 |
Why?
|
| Scattering, Small Angle | 1 | 2008 | 18 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2008 | 41 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2008 | 66 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2008 | 280 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2008 | 515 | 0.020 |
Why?
|
| Binding Sites | 1 | 2008 | 671 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 2006 | 30 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2006 | 122 | 0.010 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2005 | 3 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2006 | 49 | 0.010 |
Why?
|
| Ribonucleoproteins | 1 | 2005 | 31 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2008 | 876 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2005 | 141 | 0.010 |
Why?
|
| Phylogeny | 1 | 2008 | 769 | 0.010 |
Why?
|
| Mitosis | 1 | 2005 | 114 | 0.010 |
Why?
|
| Glucagon | 1 | 1983 | 7 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1983 | 38 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1983 | 77 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 112 | 0.010 |
Why?
|
| Anesthesia, Obstetrical | 1 | 1961 | 8 | 0.010 |
Why?
|
| Methotrimeprazine | 1 | 1961 | 1 | 0.010 |
Why?
|
| Phenothiazines | 1 | 1961 | 6 | 0.010 |
Why?
|
| Lysine | 1 | 2002 | 119 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 1621 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1983 | 403 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 1961 | 140 | 0.010 |
Why?
|
| Male | 1 | 1998 | 23409 | 0.010 |
Why?
|
| Rats | 1 | 1983 | 3735 | 0.010 |
Why?
|
| Trichloroethylene | 1 | 1949 | 2 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1961 | 972 | 0.000 |
Why?
|
| Pregnancy | 1 | 1961 | 1772 | 0.000 |
Why?
|